In the second part of a two-part series, “Research Roundtable” highlights additional elements of the “Study Registration” FAQ section from ClinicalTrials.gov.
ClinicalTrials.gov has an extensive FAQ section ranging from general to investigation-specific. This edition of “Research Roundtable” highlights a selected FAQ, “Study Registration.”
In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R.
The National Institutes of Health (NIH) recently initiated email notifications to administrative authorities at research institutions that have study records that are not compliant with ClinicalTrials.gov regulations.
In August 2022, the NIH implemented a series of changes to its internal procedures to ensure that scientists are complying with requirements to register studies and submit study results to ClinicalTrials.gov.
The new institute will streamline efforts to turn groundbreaking drug research into viable treatments and medicines, bringing new companies and new jobs.
